scholarly journals Primary cardiac diffuse large B cell lymphoma presenting with superior vena cava syndrome

2009 ◽  
Vol 25 (6) ◽  
pp. e210-e212 ◽  
Author(s):  
Amer Johri ◽  
Tara Baetz ◽  
Phillip A. Isotalo ◽  
Robert L. Nolan ◽  
Anthony J. Sanfilippo ◽  
...  
2017 ◽  
Vol 56 (15) ◽  
pp. 2043-2047 ◽  
Author(s):  
Shingen Nakamura ◽  
Kumiko Kagawa ◽  
Ryohei Sumitani ◽  
Munenori Uemura ◽  
Mamiko Takahashi ◽  
...  

2013 ◽  
Vol 24 ◽  
pp. e176-e177 ◽  
Author(s):  
L. Ruzickova ◽  
C. Canha ◽  
L. Geraldes ◽  
P. César ◽  
J. Carda ◽  
...  

2012 ◽  
Vol 155 ◽  
pp. S141-S142
Author(s):  
O. Turak ◽  
A. Yalçinkaya ◽  
F. Özcan ◽  
I. Taşoğlu ◽  
Kumral çağli ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Lauren Brownhalls ◽  
Ann Gillett ◽  
Yasmin Whately ◽  
Keisuke Tanaka

Primary mediastinal large B cell lymphoma (PMLBCL) is a subtype of non-Hodgkin’s lymphoma which presents rarely in pregnancy. It is an aggressive tumour that is associated with symptoms of superior vena cava (SVC) compression and airway compromise such as dyspnoea, facial and arm swelling, cough, or chest pain. Timely diagnosis is imperative to optimising patient outcomes and reducing both maternal and fetal morbidity and mortality. We report a case of a 33-year-old woman diagnosed with PMLBCL who presented at 33-week gestation with SVC obstruction to 1 mm in diameter. After multidisciplinary team discussion regarding maternal and fetal implications of management options, we proceeded to a caesarean section and initiated chemotherapy postdelivery. Lower segment caesarean section was uncomplicated, and she underwent a cycle of R-CHOEP followed by 5 cycles of DA-EPOCH. Eighteen months since the completion of the chemotherapy, the disease remained in remission.


2018 ◽  
Vol 5 (1) ◽  
pp. 12-15 ◽  
Author(s):  
Mehmet Zahid Kocak ◽  
◽  
Gulali Aktas ◽  
Edip Erkus ◽  
Burcin Atak ◽  
...  

2021 ◽  
pp. 107815522110351
Author(s):  
Atakan Tekinalp ◽  
Taha U Kars ◽  
Hatice Z Dikici ◽  
Pınar D Yılmaz ◽  
Sinan Demircioğlu ◽  
...  

Introduction Cardiac involvement in diffuse large B-cell lymphoma is a rare entity in non-Hodgkin lymphomas. Symptoms are usually related to heart failure. Patients who are severely symptomatic due to cardiac mass could be considered treatment as soon as possible. In this report, we present a patient diagnosed with diffuse large B-cell lymphoma with cardiac involvement. Case Report A 61-year-old female patient was admitted to our unit with gastric biopsy diffuse large B-cell lymphoma. Computerized tomography of the chest and positron emission tomography/computed tomography demonstrated a neoplastic mass in the intra-atrial septum extended to inferior vena cava (5 × 4 cm in size and standardized uptake value maximum 24.6). She was in stage III and in the high-risk group. Because of pronounced heart failure findings associated with the mass-specific chemotherapy was planned early. Management & Outcome Although a fraction of ejection was 60% by echocardiography before the treatment, she had a cardiac risk for doxorubicin due to being over 60 years old and hypertension. Complete remission was achieved after three cycles of rituximab–cyclophosphamide–doxorubicin–vincristine and methylprednisolone protocol including doxorubicin. Treatment was completed with six cycles and she was followed up for three months. Discussion Because of the cardiotoxicity of doxorubicin-based protocols, patients should be evaluated according to cardiac functions before and during the chemotherapy.


Sign in / Sign up

Export Citation Format

Share Document